Company: MIRA
Filing Date: 2025-06-17
Form Type: PREM14A
Source: 0001641172-25-015340
Chunk: 210

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-06-17
Form: PREM14A
Chunk 210
---
 the Patent Rights (the “Term”),
unless earlier terminated in accordance with the provisions of this Article 8.

8.2 .
Licensee may terminate this Agreement at any time during the Term upon thirty (30) days’ prior written notice to Licensor.

8.3 .
Licensor may terminate this Agreement immediately, if Licensee (a) becomes insolvent or is unable to pay its debts when due, (b) files
a petition in bankruptcy, reorganization or similar proceedings (and if filed against, such petition is not removed within thirty (30)
days), (c) discontinues its business, or (d) a receiver is appointed or there is an assignment for the benefit of Licensee’s creditors.

8.4 . In the event that (i) either Party commits a material breach of its obligations under this Agreement, excluding
Licensee’s obligation under Section 7.2 hereof to use commercially reasonable efforts to develop the Licensed Product, or (ii) Licensee
fails to pay any amount to Licensor hereunder when such amount is due and payable, and the breaching Party fails to cure that breach within
thirty (30) days after receiving written notice thereof from the non-breaching Party, the non-breaching Party may terminate this Agreement
immediately upon written notice to the breaching Party. In the event that Licensee breaches its obligation under Section 7.2 hereof to
use commercially reasonable efforts to develop the Licensed Product and fails to cure that breach within one hundred and twenty (120)
days after receiving written notice thereof from Licensor, Licensor may terminate this Agreement immediately upon written notice to Licensee.

<div align='center'>ARTICLE 9—MISCELLANEOUS</div>

9.1 .
Nothing in this Agreement is or shall be deemed to constitute a partnership, agency, employee or joint venture relationship between the
Parties. No Party shall incur any debts or make any commitments for the other, except to the extent, if at all, specifically provided
herein.

9.2 . Except
as expressly provided hereunder, neither this Agreement nor any rights or obligations hereunder may be assigned or otherwise transferred
without the prior written consent of the other Party; provided however, that each Party will have the right to assign this Agreement and
its rights and obligations hereunder without the other Party’s consent in connection with the transfer or sale of all or substantially
all of the business of the Party to which this Agreement relates to a third party